多参数磁共振-经直肠超声融合与系统性经直肠超声前列腺穿刺活检的并发症发生率比较
这项单中心回顾性研究比较了967例男性经直肠超声系统性前列腺穿刺与磁共振-经直肠超声融合穿刺的并发症发生率。系统性穿刺组319例,融合穿刺组648例,两组并发症发生率分别为1.9%和1.7%,差异无统计学意义(p=0.873),均未观察到严重并发症,早期与晚期并发症组间亦无统计学差异(p>0.999)。
要点
- 系统性经直肠超声前列腺穿刺组并发症发生率为1.9%(6例),融合穿刺组为1.7%(11例),两组差异无统计学意义(p=0.873)。
- 两组均未观察到严重并发症。
- 早期与晚期并发症组间无统计学差异(p>0.999)。
核心结论
- 系统性经直肠超声前列腺穿刺与磁共振-经直肠超声融合前列腺穿刺的并发症发生率均低,无关键临床结局,两种技术间并发症发生率无显著差异。
研究设计与样本
- 单中心回顾性研究,经机构审查委员会批准,比较967例男性的系统性经直肠超声前列腺穿刺与磁共振-经直肠超声融合前列腺穿刺的并发症发生率;其中319例接受系统性经直肠超声前列腺穿刺,648例接受系统性经直肠超声联合磁共振-经直肠超声融合前列腺穿刺。
诊断标准与关键数值
- 并发症分为即刻并发症(住院观察期间发生)和晚期并发症(活检后5天内发生)。
- 系统性经直肠超声前列腺穿刺组并发症发生率为1.9%(6例),融合穿刺组为1.7%(11例),两组比较p=0.873。
- 早期与晚期并发症组间比较p>0.999。
临床应用与阅片要点
- 原文结论指出两种穿刺技术的并发症发生率均低,且无显著差异(p=0.873),原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to compare the complication rates between transrectal ultrasound (TRUS) systematic prostate biopsy and multiparametric magnetic resonance imaging (MRI)-TRUS fusion prostate biopsy techniques.
MATERIALS AND METHODS: This is a single-center retrospective study, institutional review board approved. Systematic TRUS and MRI-TRUS fusion prostate biopsy complication rates were compared in 967 men. A total of 319 patients were received systematic TRUS prostate biopsy and 648 patients underwent systematic TRUS + MRI-TRUS fusion prostate biopsy. Complications were divided into immediate (those that occurred during the hospital observation period) and late (those that occurred within 5 days after biopsy).
RESULTS: Seventeen complications were observed in patients who received either a systematic prostate biopsy or MRI-TRUS fusion prostate biopsy. Severe complications were not observed in both groups. Among patients who underwent systematic prostate biopsy, 6 (1.9%) cases of complications were observed and between those who received MRI-TRUS fusion prostate biopsy 11 (1.7%) cases of complications after the procedure (p = 0.873) were observed, with no statistical difference between groups. Also, no statistical differences between early and late complication groups (p > 0.999) were observed.
CONCLUSIONS: The complication rates were low in both groups, with no critical clinical outcomes and no significant difference of complication rates between systematic TRUS prostate biopsy and MRI-TRUS fusion prostate biopsy techniques.
引用
- Queiroz MRG, Falsarella PM, Mariotti GC, et al. Comparison of complications rates between multiparametric magnetic resonance imaging-transrectal ultrasound (TRUS) fusion and systematic TRUS prostatic biopsies. Abdom Radiol (NY). 2019. PMID: 30255444. doi:10.1007/s00261-018-1782-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。